With FDA verging on its first COVID booster approval, Pfizer and Moderna will have to recalibrate revenues—againnews2021-08-12T14:00:58+00:00August 12th, 2021|Fierce Pharma|
Biden backs Medicare negotiations and price-hike penalties. But will Congress go along?news2021-08-12T13:39:07+00:00August 12th, 2021|Fierce Pharma|
Merck, Eisai’s Keytruda-Lenvima combo rides strong data to FDA nod in kidney cancer—and it’s bad news for Pfizernews2021-08-12T12:10:53+00:00August 12th, 2021|Fierce Pharma|
NY manufacturer SterRx recalls 3 lots of sodium bicarbonate because of microbial contaminationnews2021-08-12T11:02:50+00:00August 12th, 2021|Fierce Pharma|
Evotec’s new Washington site is ready to roll, and the U.S. has already called first dibs for COVID-19 antibody suppliesnews2021-08-12T04:26:34+00:00August 12th, 2021|Fierce Pharma|
Bristol Myers Squibb partners with HBCUs to attract Black students to pharma careersnews2021-08-11T21:48:07+00:00August 11th, 2021|Fierce Pharma|
Pfizer, Moderna COVID vaccines face new safety probe in Europe over possible link to skin condition, 2 kidney disordersnews2021-08-11T18:43:51+00:00August 11th, 2021|Fierce Pharma|
Biogen’s controversial Alzheimer’s med Aduhelm turned away by VA on efficacy and safety worriesnews2021-08-11T15:35:18+00:00August 11th, 2021|Fierce Pharma|
Moderna’s sky-high market value ‘unjustifiable’ to one analyst, story stock to another as it tops the likes of Merck and Amgennews2021-08-11T15:27:39+00:00August 11th, 2021|Fierce Pharma|
Facebook bans ad agency behind outlandish campaign deriding Pfizer, AstraZeneca vaccinesnews2021-08-11T15:06:29+00:00August 11th, 2021|Fierce Pharma|
